This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Non–Vitamin K Antagonist Oral Anticoagulant vs Warfarin for Post Cardiac Surgery Atrial Fibrillation

Friday, November 12, 2021

Submitted by


Source Name: The Annals of Thoracic Surgery


Victor Nauffal, MD, Ludovic Trinquart, PhD, Asishana Osho, MD, Thoralf M. Sundt, MD, Steven A. Lubitz, MD, MPH, Patrick T. Ellinor, MD, PhD

Treatment guidelines for nonvalvular atrial fibrillation (AF) recommend use of non–vitamin K antagonist oral anticoagulants (NOACs) over warfarin. However, clinical trials did not include individuals with post cardiac surgery AF. We sought to compare outcomes with NOACs vs warfarin for new onset post cardiac surgery AF.


Patient operated with MVR with Tissue valve with AF ablation post op 2 years reverted to A F with controlled heart rate. What is better NOACs or warfarin

Add comment

Log in or register to post comments